Dashboard
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 9.04%
- Poor long term growth as Operating profit has grown by an annual rate of -23.72%
Stock is technically in a Bearish range
With ROE of -3.6, it has a Very Expensive valuation with a 0.5 Price to Book Value
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Trading & Distributors
INR 23 Cr (Micro Cap)
NA (Loss Making)
20
0.00%
1.43
-3.65%
0.48
Total Returns (Price + Dividend) 
Latest dividend: 0.1 per share ex-dividend date: Jun-23-2023
Risk Adjusted Returns v/s 
Returns Beta
News

Medico Intercontinental Ltd is Rated Strong Sell
Medico Intercontinental Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 14 August 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 09 October 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read More Announcements 
Board Meeting Outcome for Outcome Of Board Meeting Dated November 06 2026
06-Nov-2026 | Source : BSEOutcome of Board Meeting dated November 06 2026.
Results - Financial Results For The Quarter And Half Year Ended September 30 2026.
06-Nov-2026 | Source : BSEFinancial Results for the Quarter and Half year ended September 30 2026.
Board Meeting Intimation for Compliance Of Regulation 29 30 And 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.
29-Oct-2026 | Source : BSEMedico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 inter alia to consider and approve and take on record the unaudited Financial Results (Standalone and Consolidated) for quarter and half year ended 30th September 2026 and any other business items as per agenda circulated.
Corporate Actions 
No Upcoming Board Meetings
Medico Intercontinental Ltd has declared 1% dividend, ex-date: 23 Jun 23
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Shah Samir (47.77%)
Dd Master Huf . (1.24%)
35.39%
Quarterly Results Snapshot (Consolidated) - Sep'26 - QoQ
QoQ Growth in quarter ended Sep 2026 is 10.33% vs -7.91% in Jun 2026
QoQ Growth in quarter ended Sep 2026 is 144.14% vs -123.08% in Jun 2026
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is -25.09% vs 34.61% in Sep 2024
Growth in half year ended Sep 2025 is -185.66% vs 43.92% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is -16.94% vs 33.26% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -165.55% vs 33.68% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is -11.79% vs 33.58% in Mar 2025
YoY Growth in year ended Mar 2026 is -163.24% vs 28.10% in Mar 2025